ACUTE MYELOID LEUKEMIAS
Clinical trials for ACUTE MYELOID LEUKEMIAS explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKEMIAS trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKEMIAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug tested for patients with no other options
Disease control Recruiting nowThis is a first-in-human study testing a new drug called STX-0712 in patients with advanced forms of blood cancer (CMML and AML) who have no remaining standard treatment options. The main goals are to find a safe dose and see if the drug shows any early signs of fighting the canc…
Matched conditions: ACUTE MYELOID LEUKEMIAS
Phase: PHASE1 • Sponsor: Solu Therapeutics, Inc • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Major trial aims to boost chemo power against aggressive leukemia
Disease control Recruiting nowThis large, late-stage study is testing whether adding an experimental drug called revumenib to standard chemotherapy works better than chemotherapy alone for adults newly diagnosed with a specific genetic type of acute myeloid leukemia (AML). The goal is to see if the combinatio…
Matched conditions: ACUTE MYELOID LEUKEMIAS
Phase: PHASE3 • Sponsor: Syndax Pharmaceuticals • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
New hope for Tough-to-Treat leukemia: First-in-Human trial tests novel drug combo
Disease control Recruiting nowThis study is testing the safety and early effectiveness of a new oral drug, SNDX-5613, when given alongside standard intensive chemotherapy to adults newly diagnosed with a fast-growing blood cancer called acute myeloid leukemia (AML). The trial is specifically for people whose …
Matched conditions: ACUTE MYELOID LEUKEMIAS
Phase: PHASE1 • Sponsor: Syndax Pharmaceuticals • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC